This year, for the first time, two key European Courses - the Resistant Hypertension Course (RHC) and TRENDS - will join forces, uniting their expertise and experience to offer the medical community cutting edge developments in the diagnosis and management of patients with uncontrolled hypertension. Taking place on the 27th and 28th of February at the Maritim proArte Hotel in Berlin, Germany, RHC-TRENDS 2015 represents a comprehensive and practical course on all aspects of difficult-to-treat hypertension from optimal, personalised medical management to the latest device-based treatment modalities. A special focus of this year's meeting will be the identification and prevention of Target Organ Damage.
The effective management of hypertensive patients is an individual and societal challenge aimed at a reduction in cardiovascular mortality, stroke, kidney disease and myocardial infarction. For all hypertensive patients, blood pressure reduction to an optimal range is the goal and yet, despite treatment with effective antihypertensive drugs, in some patients blood pressure remains above target. In these circumstances, a systematic holistic approach, including lifestyle counselling, antihypertensive medication adjustments and device-based therapies, is called for. RHC-TRENDS 2015, led by Course Directors Felix Mahfoud (Germany), Horst Sievert (Germany) and Kostantinos Tsioufis (Greece), offers participants the possibility of sharing and exchanging clinical and theoretical knowledge with European and International experts.
The two-day Course focuses on various aspects of care for hypertensive patients: the first day looks at case-based care, prevention, detection, and management of target organ damage, while the second day will examine device-based therapies, potential shortcomings of existing technology, and new concepts and future directions for general practitioners, interventional specialists, and scientists. A central goal of RHC-TRENDS - and a foundation of all PCR Courses - is to help practitioners answer fundamental and practical questions that impact on their daily practice. At RHC-TRENDS, one of the key questions will be, "What is the best management and technical strategy for each individual patient presenting with difficult-to-control blood pressure?"
Topics covered at RHC-TRENDS 2015 will include:
- What is "uncontrolled and apparent resistant hypertension"?
- Why is it important to identify patients with target organ damage and secondary forms of hypertension?
- How do we best manage individual patients with hypertensive target organ damage?
- Who are the optimal candidates for device-based antihypertensive therapy and what are the contraindications to this therapy?
- Basics, and tips and tricks of currently available device-based therapy for optimal procedure performance.
- Potential challenges and limitations of current and future clinical developments as well as novel concepts and technology being developed today.
RHC is a joint initiative of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Society of Hypertension (ESH), PCR Organisation and CSI/TRENDS, aiming to provide a forum for practical exchanges for the medical community managing hypertensive patients. RHC-TRENDS 2015 is aimed at physicians caring for hypertensive patients or performing interventional procedures, healthcare providers with an interest in hypertension, and scientists and engineers with an interest in device-based hypertension therapy. The Course is fully integrated with the RHC online, providing year-round access to the topics, discussions and information which are covered during RHC-TRENDS.
For more information about RHC-TRENDS, the updated interactive programme and PCR, please go to http://www.